Back to Journals » Drug Design, Development and Therapy » Volume 10
Original Research
A novel imidazopyridine derivative, X22, attenuates sepsis-induced lung and liver injury by inhibiting the inflammatory response in vitro and in vivo
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
9,996 | Dovepress* | 9,147+ | 1,635 | 10,782 | |
PubMed Central* | 849 | 244 | 1,093 | ||
Totals | 9,996 | 1,879 | 11,875 | ||
*Since 24 June 2016 +Since July 2016 |
View citations on PubMed Central and Google Scholar